Closed · RFA-FD-11-011 · CFDA 93.103 · Discretionary
Collaboration in Regulatory Science and Capacity to Advance Global Access to Safe Vaccines and Biological (U01)
Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.
- $800K-$800K
- Award range
- Closed
- Status
- July 8, 2011
- Close date
- 1
- Expected awards
The verdict
Collaboration in Regulatory Science and Capacity to Advance Global Access to Safe Vaccines and Biological (U01) is a closed discretionary listing from Food and Drug Administration that offered $800,000 -- $800,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.
- $800K-$800K
- award range
- Closed
- application status
- 1
- expected award
- 93.103
- CFDA program
Archived opportunity record
Collaboration in Regulatory Science and Capac… is closed (last close July 8, 2011). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed July 8, 2011
Est. Total Funding
$800,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
The U.S. FDAs Center for Biologics Evaluation and Research (FDA/CBER) has been a leader and active participant in the global community to improve human health in the worlds populations over many years. Its international engagements have historically been, and continue to be, framed by a simple truth: protection of global public health against infectious disease threats translates into protection of U.S. public health. FDA, through CBER, has longstanding collaborations with the WHO in the area of vaccines and biologics. For example, the FDA/CBER has been a Pan American Health Organization (PAHO)/WHO Collaborating Center for Biological Standardization since 1998. The purpose, scope and areas of activity for each term are captured in a set of Terms of Reference (TOR) mutually agreed to by FDA/CBER and WHO and are reflective of their shared interest in supporting the quality, safety and standards work of both organizations. An important additional area is the FDA/CBER's engagement with the WHO Vaccine Prequalification Program. The WHO, through the QSS/IVB, provides advice to the United Nations Children's Fund (UNICEF) and other United Nations (UN) agencies on the acceptability, in principle, of vaccines considered for purchase by such agencies for vaccination programs they administer. An important part of the Vaccine Prequalification Program is WHO's reliance upon the national regulatory authority (NRA) of the country of manufacture of the vaccine if the NRA meets the WHO indicators that qualify it as a functional NRA. In 2009, FDA entered into a arrangement with WHO/QSS to enable FDA/CBER to serve as a reference NRA under this prequalification program, and the Center is currently a reference NRA for eight U.S. licensed vaccines including five influenza vaccines.
Catch-all / unrestricted eligibility mark · RFA-FD-11-011
Grants.gov marks Collaboration in Regulatory Science and Capac… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Agriculture · Business and Commerce · Education · Employment, Labor and Training · Environment · Health · Income Security and Social Services · Natural Resources · Regional Development · Science and Technology / R&D (AG;BC;ED;ELT;ENV;HL;IS;NR;RD;ST). 119 other Food and Drug Administration listings share this eligibility-code string (25% of 482).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Food and Drug Administration Research
U.S. Department of Health and Human Services
Agency Contact
Vieda HUBBARD Grants Management Specialist Phone 301-827-7177
More from Food and Drug Administration
Federal and University Partnership to Improve the Safety of Seafood from the Gulf of America
Research, Education, and Outreach on Botanical Natural Products
Cooperative Agreement to Support Shellfish Safety Assistance Project
Education and Outreach to Tribal Producers through the Tribal Food Safety Alliance
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
What to do next
Collaboration in Regulatory Science and Capac… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
- Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
- Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |